Share：
Share this content in WeChat
X
[Chinese][PDF]680130
• Editorial •
Value of MRI follow-up in breast cancer’s diagnosis and efficacy evaluation
ZHOU Chun-wu  ZHANG Ren-zhi 

DOI:10.3969/j.issn.1674-8034.2011.03.002.


[Abstract] MRI is not only important in the detection, diagnosis of breast cancer,but also is very important in the efficacy monitoring of breast cancer' treament. A great quantity of relevant domestic and foreign classic literature during nearly 10 years were retrospectively analyzed in this paper. Elaborate about the value of MRI follow-up in the early diagnosis of precancerous change,in the diagnosis of different sorts of breast cancer, in the diagnosis of breast cancer recurrence and so on. At the same time, the value of MRI follow-up is compared with mammography and breast ultrasound using mass data in published papers. The application of MRI in breast cancer neoadjuvant chemotherapy is also discussed. Based on the clinical work, some cases' images are used as instances. Breast MRI related technical requirements and the matters needing attention are noted.
[Keywords] Breast cancer；Magnetic resonance imaging；Follow-up；Efficacy evaluation

ZHOU Chun-wu Department of Diagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China

ZHANG Ren-zhi* Department of Diagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China

*Correspondence to: Zhang RZ, E-mail: zhangrenzhi7790@126.com

Conflicts of interest   None.

Received  2011-03-21
Accepted  2011-04-28
DOI: 10.3969/j.issn.1674-8034.2011.03.002
DOI:10.3969/j.issn.1674-8034.2011.03.002.

[1]
Carbognin G, Girardi V, Brandalise A, et al. MR-guided vacuum-assisted breast biopsy in the management of incidental enhancing lesions detected by breast MR imaging. Radiol Med, 2011 DOI: . DOI:
[2]
Pediconi F, Padula S, Dominelli V, et al. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation. Radiology, 257(3):653-661.
[3]
Crystal P, Sadaf A, Bukhanov K, et al. High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: can underestimation be predicted? Eur Radiol, 21(3):582-589.
[4]
Strigel RM, Eby PR, Demartini WB, et al. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI. AJR Am J Roentgenol, 195(3):792-798.
[5]
Moore NR, Dixon AK, Wheeler TK, et al. Axillary fibrosis or recurrent tumour. An MRI study in breast cancer. Clin Radiol, 1990, 42(1):42-46.
[6]
Heywang-Kobrunner SH, Schlegel A, Beck R, et al. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy. J Comput Assist Tomogr, 1993, 17(6):891-900.
[7]
Bone B, Aspelin P, Isberg B, et al. Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery. Acta Radiol, 1995, 36(2):111-116.
[8]
Gilles R, Thiollier S, Guinebretiere JM, et al. Diagnosis of local breast cancer recurrences by magnetic resonance imaging. J Gynecol Obstet Biol Reprod (Paris), 1995, 24(8):788-793.
[9]
Viehweg P, Heinig A, Lampe D, et al. Retrospective analysis for evaluation of the value of contrast-enhanced MRI in patients treated with breast conservative therapy. MAGMA, 1998, 7(3):141-152.
[10]
Muuller RD, Barkhausen J, Sauerwein W, et al. Assessment of local recurrence after breast-conserving therapy with MRI. J Comput Assist Tomogr, 1998, 22(3):408-412.
[11]
Aichinger U, Schulz-Wendtland R, Kramer S, et al. Scar or recurrence--comparison of MRI and color-coded ultrasound with echo signal amplifiers. Rofo, 2002, 174(11):1395-1401.
[12]
Preda L, Villa G, Rizzo S, et al. Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy. Breast Cancer Res, 2006, 8(5):R53.
[13]
Guerra LE, Smith RM, Kaminski A, et al. Invasive local recurrence increased after radiation therapy for ductal carcinoma in situ. Am J Surg, 2008, 196(4):552-555.
[14]
Elmore L, Margenthaler JA. Breast MRI surveillance in women with prior curative-intent therapy for breast cancer. J Surg Res, 163(1):58-62.
[15]
Drew PJ, Kerin MJ, Turnbull LW, et al. Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast. Ann Surg Oncol, 1998, 5(3):265-270.
[16]
Kramer S, Schulz-Wendtland R, Hagedorn K, et al. Magnetic resonance imaging in the diagnosis of local recurrences in breast cancer. Anticancer Res, 1998, 18(3C):2159-2161.
[17]
Yilmaz MH, Esen G, Ayarcan Y, et al. The role of US and MR imaging in detecting local chest wall tumor recurrence after mastectomy. Diagn Interv Radiol, 2007, 13(1):13-18.
[18]
Khatcheressian JL, Wolff AC, Smith TJ, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol, 2006, 24(31):5091-5097.
[19]
Bahri S, Chen JH, Yu HJ, et al. Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer? Ann Oncol, 2008, 19(4):822-824.
[20]
Pan L, Han Y, Sun X, et al. FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis. J Cancer Res Clin Oncol, 136(7):1007-1022.
[21]
Rieber A, Tomczak RJ, Mergo PJ, et al. MRI of the breast in the differential diagnosis of mastitis versus inflammatory carcinoma and follow-up. J Comput Assist Tomogr, 1997, 21(1):128-132.
[22]
Fischer U, Vosshenrich R, von Heyden D, et al. Inflammatory lesions of the breast: indication for MR-mammography? Rofo, 1994, 161(4):307-311.
[23]
de Bresser J, de Vos B, van der Ent F. et al. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. Eur J Surg Oncol, 2009, 36(2):114-119.
[24]
Mann RM. The effectiveness of MR imaging in the assessment of invasive lobular carcinoma of the breast. Magn Reson Imaging Clin N Am, 2010, 18(2):259-276.
[25]
Garimella V, Qutob O, Fox JN, et al. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients. Eur J Surg Oncol, 2007, 33(2):157-161.
[26]
Nagashima T, Sakakibara M, Sangai T, et al. Tumor reduction rate predicts early recurrence in patients with breast cancer failing to achieve complete response to primary chemotherapy. Breast Cancer, 2010, 17(2):125-130.
[27]
Maur M, Guarneri V, Frassoldati A, et al. Primary systemic therapy in operable breast cancer: clinical data and biological fall-out. Ann Oncology, 2006, 17(suppl 5):v158-v164.
[28]
Sachelarie I, Grossbard ML, Chadha M, et al. Primary systemic therapy of breast cancer. Oncologist, 2006, 11(6):574-589.
[29]
Vanessa N, Scott I, David E, et al. Use of new imaging technique to predict tumor response to therapy. Lancet Oncol, 2010, 11(1):92-102.
[30]
Sliverstein MJ, Lagios MD, Recht A, et al. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg, 2005, 201(4):586-589.
[31]
Yankeelov TE, Lepage M, Chakravarthy A, et al. Integration of quantitative DCE-MRI and ADC mapping tomonitor treatment response in human breast cancer: initial results. Magn Reson Imaging, 2007, 25(1):1-13.

PREV Application of breast MRI in breast cancer screening: interpretation of the latest breast imaging screening guideline issued by ACR & SBI in 2010
NEXT Clinical value of functional MRI in assessment of early response to neoadjuvant chemotherapy in breast carcinoma
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn